Transcatheter Closure of Complex Multifenestrated Atrial Septal Defect Using Three Septal Occluders: Is Three Too

Hussam Al Hennawi1, Appa Bandi2, Ahmad Abulshamat3

  • 1Department of Internal Medicine, Jefferson Abington Hospital, Abington, Pennsylvania.

Insights

This study demonstrates the successful transcatheter closure of a complex atrial septal defect (ASD) using three overlapping devices. This approach offers a viable solution for challenging multifenestrated ASD cases.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Interventional Cardiology

Background:

  • Atrial septal defects (ASDs) are prevalent in adult congenital heart disease.
  • Treatment involves surgical or transcatheter closure for symptomatic patients.
  • Transcatheter repair is established for secundum ASDs.

Purpose of the Study:

  • To report a complex transcatheter closure of an atrial septal defect.
  • To address the challenges posed by multifenestrated secundum ASDs.
  • To showcase the use of overlapping devices for intricate defects.

Main Methods:

  • Transcatheter closure of a complex secundum ASD.
  • Utilized three overlapping Amplazter devices.
  • Described the procedural approach for a multifenestrated defect.

Main Results:

  • Successful transcatheter closure of a complex atrial septal defect was achieved.
  • The use of three overlapping devices proved effective in this challenging case.
  • Demonstrated feasibility of device overlap for multifenestrated ASDs.

Conclusions:

  • Transcatheter closure is a feasible option for complex secundum ASDs.
  • Overlapping device techniques can manage multifenestrated defects.
  • This case highlights a successful strategy for challenging ASD repairs.

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
689
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
538
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598